N0 (N=249) |
N1 (N=112) |
N2 (N=58) |
P-value | |
---|---|---|---|---|
pathologic_T | ||||
T2 | 249 (100%) | 112 (100%) | 58 (100%) | <0.001 |
pathologic_M | ||||
M0 | 177 (71.1%) | 88 (78.6%) | 46 (79.3%) | 0.499 |
M1 | 8 (3.2%) | 2 (1.8%) | 1 (1.7%) | |
MX | 64 (25.7%) | 22 (19.6%) | 11 (19.0%) | |
pathologic_stage | ||||
Stage I | 206 (82.7%) | 0 (0%) | 0 (0%) | <0.001 |
Stage II | 34 (13.7%) | 109 (97.3%) | 1 (1.7%) | |
Stage IV | 8 (3.2%) | 2 (1.8%) | 1 (1.7%) | |
Stage III | 0 (0%) | 0 (0%) | 55 (94.8%) | |
Missing | 1 (0.4%) | 1 (0.9%) | 1 (1.7%) | |
Age (years) | ||||
Mean (SD) | 66.4 (10.1) | 65.3 (9.14) | 64.6 (10.1) | 0.612 |
Median [Min, Max] | 68.0 [33.0, 87.0] | 65.0 [42.0, 84.0] | 66.0 [41.0, 87.0] | |
Missing | 12 (4.8%) | 5 (4.5%) | 3 (5.2%) | |
gender | ||||
FEMALE | 91 (36.5%) | 39 (34.8%) | 25 (43.1%) | 0.555 |
MALE | 158 (63.5%) | 73 (65.2%) | 33 (56.9%) |